• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Checkpoint Therapeutics, Inc. - Common Stock (NQ:CKPT)

4.260 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.260
Bid (Size) 4.270 (97)
Ask (Size) 4.300 (20)
Prev. Close 4.260
Today's Range 4.260 - 4.260
52wk Range 2.060 - 4.500
Shares Outstanding 45,095,500
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders
April 30, 2025
From Halper Sadeh LLC
Via GlobeNewswire
CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc. - CKPT
April 29, 2025
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
+29.5%
+29.5%
1 Month
N/A
N/A
3 Month
+5.4%
+5.4%
6 Month
+53.8%
+53.8%
1 Year
+62.0%
+62.0%

More News

Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders
April 17, 2025
From Halper Sadeh LLC
Via GlobeNewswire
On Friday, there are stocks with unusual volume. Let's take a look.
March 14, 2025
Via Chartmill
CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc. - CKPT
March 14, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, CKPT, AMPY on Behalf of Shareholders
March 12, 2025
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq - CKPT), Redfin Corporation (Nasdaq - RDFN), Amplify Energy Corp. (NYSE - AMPY), Blackboxstocks Inc. (Nasdaq - BLBX)
March 12, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
Unusual volume stocks are being observed in Wednesday's session.
March 12, 2025
Via Chartmill
Unusual volume stocks are being observed in Tuesday's session.
March 11, 2025
Via Chartmill
Rocket Companies (NYSE: RKT) to Acquire Redfin (NASDAQ: RDFN) in $1.75B Deal – More Stocks to Watch Inside!
March 11, 2025
Via AB Newswire
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
March 11, 2025
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CKPT, RDFN, BLBX on Behalf of Shareholders
March 10, 2025
From Halper Sadeh LLC
Via GlobeNewswire
Keep an eye on the top gainers and losers in Monday's session.
March 10, 2025
Via Chartmill
Monday's session: top gainers and losers
March 10, 2025
Via Chartmill
Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher
March 10, 2025
Via Benzinga
Topics Stocks
Let's uncover which stocks are experiencing notable gaps during today's session.
March 10, 2025
Via Chartmill
India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details
March 10, 2025
Via Benzinga
Nasdaq Dips Over 3%; Checkpoint Therapeutics Shares Jump
March 10, 2025
Via Benzinga
Top movers in Monday's pre-market session
March 10, 2025
Via Chartmill
CKPT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Checkpoint Therapeutics, Inc. Is Fair to Shareholders
March 10, 2025
From Halper Sadeh LLC
Via Business Wire
US Stocks Likely To Open Lower After Trump Hints At Looming Recession: Expert Says Can't Rule Out A Bear Market As Indices Inch Towards Correction Territory
March 10, 2025
Via Benzinga
Topics Government
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
March 10, 2025
Via Benzinga
Shareholder Alert: The Ademi Firm Investigates Whether Checkpoint Therapeutics, Inc. is Obtaining a Fair Price for Its Public Shareholders
March 10, 2025
From Ademi & Fruchter LLP
Via Business Wire
This PG&E Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
January 13, 2025
Via Benzinga
Adoption of Autonomous Drones Rises for Military Operations Fueled by Cutting-Edge Technology
January 02, 2025
Via FinancialNewsMedia
Topics Artificial Intelligence

Frequently Asked Questions

Is Checkpoint Therapeutics, Inc. - Common Stock publicly traded?
Yes, Checkpoint Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Checkpoint Therapeutics, Inc. - Common Stock trade on?
Checkpoint Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Checkpoint Therapeutics, Inc. - Common Stock?
The ticker symbol for Checkpoint Therapeutics, Inc. - Common Stock is CKPT on the Nasdaq Stock Market
What is the current price of Checkpoint Therapeutics, Inc. - Common Stock?
The current price of Checkpoint Therapeutics, Inc. - Common Stock is 4.260
When was Checkpoint Therapeutics, Inc. - Common Stock last traded?
The last trade of Checkpoint Therapeutics, Inc. - Common Stock was at 05/29/25 04:00 PM ET
What is the market capitalization of Checkpoint Therapeutics, Inc. - Common Stock?
The market capitalization of Checkpoint Therapeutics, Inc. - Common Stock is 192.11M
How many shares of Checkpoint Therapeutics, Inc. - Common Stock are outstanding?
Checkpoint Therapeutics, Inc. - Common Stock has 192M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap